Ribavirin concentration in the later stages of 48 week pegylated interferon-α2b plus ribavirin therapy for chronic hepatitis C is useful for predicting virological response

Norihiro Furusyo, Masayuki Murata, Eiichi Ogawa, Kazuhiro Toyoda, Takeshi Ihara, Hiroaki Ikezaki, Takeo Hayashi, Tsunehisa Koga, Mosaburo Kainuma, Jun Hayashi

Research output: Contribution to journal › Article › peer-review

23 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Ribavirin concentration in the later stages of 48 week pegylated interferon-α2b plus ribavirin therapy for chronic hepatitis C is useful for predicting virological response'. Together they form a unique fingerprint.

Nursing and Health Professions

Biochemistry, Genetics and Molecular Biology